oxymetazoline has been researched along with Keratoconjunctivitis in 1 studies
Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.
Keratoconjunctivitis: Simultaneous inflammation of the cornea and conjunctiva.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hutter, H | 1 |
1 trial available for oxymetazoline and Keratoconjunctivitis
Article | Year |
---|---|
[Epidemic keratoconjunctivitis: treatment results during an epidemic].
Topics: Acrylic Resins; Adenovirus Infections, Human; Adolescent; Adult; Aged; Aged, 80 and over; Child; Chi | 1990 |